降低肝癌发病率的新指南

StephenW

降低肝癌发病率的新指南
蔡文君
  14:42 UTC+8, 2022-01-09

全球每年报告的新发肝癌病例中，有一半以上在中国。

肝癌已成为全国第四大流行癌症和第二大癌症相关死因。

周六，当新版国家肝癌诊疗指南在上海发布时，医学专家表示，五年生存率约为 12.2%。

专家表示，提高肝癌治疗的医疗能力对于帮助实现国家政府到2030年将各类癌症平均五年生存率提高15%的计划具有重要意义。

上海中山医院院长、指导专家范佳博士说：“新指南代表了肝癌诊断和治疗的最高医学能力，包含了规范和加强临床实践的最新和最高水平的医学证据。” .

“它重申了早期筛查、诊断和治疗的重要性，也重视对患者及其家属的心理护理。我们希望新的指导有助于提高治疗效果，延长患者的生存期，改善他们的生活质量。”

我国肝癌高发的原因与乙肝感染的流行有关。

“大约 77% 的肝癌病例是由乙型肝炎感染引起的，大多数患者直到中期或晚期才被诊断出来，失去了手术或其他区域治疗的机会，”另一位新的首席专家秦树奎博士说。指导。 “我们需要为患者提供更多创新药物和治疗计划。”

新的指导意见将由国家卫健委尽快公布，在全国推广。
来源：SHINE 编辑：蔡文君

StephenW

New guidance in place to lower incidence of liver cancer
Cai Wenjun
  14:42 UTC+8, 2022-01-09      

More than half of the newly diagnosed liver cancer cases annually reported in the world are in China.

Liver cancer has become the fourth most prevalent cancer and second cancer-related cause of death in the nation.

The five-year survival rate is about 12.2 percent, medical experts said on Saturday, when a new version of the national guidance on liver cancer diagnosis and treatment was released in Shanghai.

Improving medical ability for treating liver cancer is important to help achieve the national government's plan to prolong the average five-year survival rate of all types of cancer by 15 percent by 2030, experts said.

"The new guidance represents the highest medical ability for liver cancer diagnosis and treatment and includes the latest and the highest level of medical evidence to regulate and enhance clinical practice," said Dr Fan Jia, president of Shanghai's Zhongshan Hospital and a leading expert of guidance.

"It reiterates the importance of early screening, diagnosis and treatment and also pays attention to psychological care for patients and their families. We hope the new guidance will help improve treatment effects, prolong patients' survival and better their life quality."

The reason for the high prevalence of liver cancer in China is related to the prevalence of hepatitis B infection.

"About 77 percent of liver cancer cases are caused by hepatitis B infection and most patients are not diagnosed until in the middle or terminal stages, losing the opportunity for surgery or other regional treatments," said Dr Qin Shukui, another leading expert for the new guidance. "We need more innovative medicines and treatment plans for patients."

The new guidance will be publicized by the National Health Commission soon for nationwide promotion.
Source: SHINE   Editor: Cai Wenjun

newchinabok

看了癌版，有时庆幸自己还活着。

没有核苷药，许多人都挂了

hchu

上帝的礼物，TAF。